Importer of Controlled Substances Application: Meridian Medical Technologies, LLC, 14290-14291 [2022-05291]
Download as PDF
<![CDATA[
14290
Federal Register / Vol. 87, No. 49 / Monday, March 14, 2022 / Notices
No other activities for these drug codes
are authorized for this registration.
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Drug
code
Schedule
9220
II
Matthew J. Strait,
Deputy Assistant Administrator.
Levorphanol ....................
Bulk Manufacturer of Controlled
Substances Application: Janssen
Pharmaceuticals Inc.
[FR Doc. 2022–05314 Filed 3–11–22; 8:45 am]
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
DEPARTMENT OF JUSTICE
The company plans to bulk
manufacture the listed controlled
substances for the internal use or for
sale to its customers. No other activities
for these drug codes are authorized for
this registration.
[Docket No. DEA–982]
BILLING CODE P
AGENCY:
Drug Enforcement Administration
Janssen Pharmaceuticals Inc.,
has applied to be registered as a bulk
manufacturer of basic class(es) of
controlled substance(s). Refer to
SUPPLEMENTAL INFORMATION listed below
for further drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before May 13, 2022. Such persons
may also file a written request for a
hearing on the application on or before
May 13, 2022.
ADDRESSES: DEA requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.’’
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.33(a), this
is notice that on December 10, 2021,
Janssen Pharmaceuticals Inc., 1440
Olympic Drive Athens, Georgia 30601–
1645, applied to be registered as a bulk
manufacturer of the following basic
class(es) of controlled substance(s):
SUMMARY:
Controlled substance
jspears on DSK121TN23PROD with NOTICES1
Controlled substance
Methylphenidate .............
Hydromorphone ..............
Hydrocodone ..................
Oripavine ........................
Thebaine .........................
Tapentadol ......................
Drug
code
Schedule
1724
9150
9193
9330
9333
9780
II
II
II
II
II
II
[Docket No. DEA–978]
Bulk Manufacturer of Controlled
Substances: ANI Pharmaceuticals, Inc.
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
VerDate Sep<11>2014
17:51 Mar 11, 2022
Jkt 256001
[FR Doc. 2022–05323 Filed 3–11–22; 8:45 am]
BILLING CODE P
AGENCY:
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
ANI Pharmaceuticals, Inc.,
has applied to be registered as a bulk
manufacturer of basic class(es) of
controlled substance(s). Refer to
SUPPLEMENTAL INFORMATION listed below
for further drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before May 13, 2022. Such persons
may also file a written request for a
hearing on the application on or before
May 13, 2022.
ADDRESSES: The DEA requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.’’
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.33(a), this
is notice that on January 6, 2022, ANI
Pharmaceuticals, Inc., 70 Lake Drive,
East Windsor, New Jersey 08520,
applied to be registered as a bulk
manufacturer of the following basic
class(es) of controlled substance(s):
SUMMARY:
Controlled substance
The company plans to manufacture
the above-listed controlled substances
in bulk for distribution to its customers.
Matthew J. Strait,
Deputy Assistant Administrator.
Psilocybin .......................
Psilocyn ..........................
PO 00000
Frm 00054
Fmt 4703
Drug
code
Schedule
7437
7438
I
I
Sfmt 4703
[Docket No. DEA–976]
Importer of Controlled Substances
Application: Meridian Medical
Technologies, LLC
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Meridian Medical
Technologies, LLC, has applied to be
registered as an importer of basic
class(es) of controlled substance(s).
Refer to SUPPLEMENTARY INFORMATION
listed below for further drug
information.
SUMMARY:
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before April 13, 2022. Such
persons may also file a written request
for a hearing on the application on or
before April 13, 2022.
ADDRESSES: The DEA requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment. All
requests for a hearing must be sent to:
(1) Drug Enforcement Administration,
Attn: Hearing Clerk/OALJ, 8701
DATES:
E:\FR\FM\14MRN1.SGM
14MRN1
14291
Federal Register / Vol. 87, No. 49 / Monday, March 14, 2022 / Notices
Morrissette Drive, Springfield, Virginia
22152; and (2) Drug Enforcement
Administration, Attn: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing should
also be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152.
In
accordance with 21 CFR 1301.34(a), this
is notice that on February 2, 2022,
Meridian Medical Technologies, LLC,
2555 Hermelin Drive, Saint Louis,
Missouri 63144, applied to be registered
as an importer of the following basic
class(es) of controlled substance(s):
SUPPLEMENTARY INFORMATION:
Controlled substance
Morphine .........................
Drug
code
Schedule
9300
II
The company plans to import the
control substance for analytical and
research purposes. No other activity for
this drug code is authorized for this
registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or non-
approved finished dosage forms for
commercial sale.
Matthew J. Strait,
Deputy Assistant Administrator.
[FR Doc. 2022–05291 Filed 3–11–22; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–981]
Importer of Controlled Substances
Application: Sigma Aldrich Co. LLC
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Sigma Aldrich Co. LLC has
applied to be registered as an importer
of basic class(es) of controlled
substance(s). Refer to Supplemental
Information listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before April 13, 2022. Such
persons may also file a written request
for a hearing on the application on or
before April 13, 2022.
ADDRESSES: DEA requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
SUMMARY:
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment. All
requests for a hearing must be sent to:
(1) Drug Enforcement Administration,
Attn: Hearing Clerk/OALJ, 8701
Morrissette Drive, Springfield, Virginia
22152; and (2) Drug Enforcement
Administration, Attn: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing should
also be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152.
In
accordance with 21 CFR 1301.34(a), this
is notice that on January 21, 2022,
Sigma Aldrich Co. LLC, 3500 Dekalb
Street, Saint Louis, Missouri 63118–
4103, applied to be registered as an
importer of the following basic class(es)
of controlled substance(s):
SUPPLEMENTARY INFORMATION:
jspears on DSK121TN23PROD with NOTICES1
Controlled substance
Drug code
Cathinone ...............................................................................................................................................................................
Methcathinone ........................................................................................................................................................................
Mephedrone (4-Methyl-N-methylcathinone) ...........................................................................................................................
Gamma Hydroxybutyric Acid ..................................................................................................................................................
Tetrahydrocannabinols ...........................................................................................................................................................
4-Bromo-2,5-dimethoxyamphetamine ....................................................................................................................................
4-Bromo-2,5-dimethoxyphenethylamine .................................................................................................................................
2,5-Dimethoxyamphetamine ...................................................................................................................................................
3,4-Methylenedioxyamphetamine ...........................................................................................................................................
3,4-Methylenedioxy-N-ethylamphetamine ..............................................................................................................................
3,4-Methylenedioxymethamphetamine ...................................................................................................................................
4-Methoxyamphetamine .........................................................................................................................................................
Dimethyltryptamine .................................................................................................................................................................
N-Benzylpiperazine ................................................................................................................................................................
Heroin .....................................................................................................................................................................................
Normorphine ...........................................................................................................................................................................
Amobarbital ............................................................................................................................................................................
Secobarbital ............................................................................................................................................................................
Nabilone .................................................................................................................................................................................
Phencyclidine .........................................................................................................................................................................
Ecgonine .................................................................................................................................................................................
Ethylmorphine .........................................................................................................................................................................
Levorphanol ............................................................................................................................................................................
Meperidine ..............................................................................................................................................................................
Thebaine .................................................................................................................................................................................
Opium, powdered ...................................................................................................................................................................
Levo-alphacetylmethadol ........................................................................................................................................................
VerDate Sep<11>2014
17:51 Mar 11, 2022
Jkt 256001
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
E:\FR\FM\14MRN1.SGM
14MRN1
1235
1237
1248
2010
7370
7391
7392
7396
7400
7404
7405
7411
7435
7493
9200
9313
2125
2315
7379
7471
9180
9190
9220
9230
9333
9639
9648
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
]]>Agencies
[Federal Register Volume 87, Number 49 (Monday, March 14, 2022)]
[Notices]
[Pages 14290-14291]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-05291]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-976]
Importer of Controlled Substances Application: Meridian Medical
Technologies, LLC
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Meridian Medical Technologies, LLC, has applied to be
registered as an importer of basic class(es) of controlled
substance(s). Refer to Supplementary Information listed below for
further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
April 13, 2022. Such persons may also file a written request for a
hearing on the application on or before April 13, 2022.
ADDRESSES: The DEA requires that all comments be submitted
electronically through the Federal eRulemaking Portal, which provides
the ability to type short comments directly into the comment field on
the web page or attach a file for lengthier comments. Please go to
https://www.regulations.gov and follow the online instructions at that
site for submitting comments. Upon submission of your comment, you will
receive a Comment Tracking Number. Please be aware that submitted
comments are not instantaneously available for public view on https://www.regulations.gov. If you have received a Comment Tracking Number,
your comment has been successfully submitted and there is no need to
resubmit the same comment. All requests for a hearing must be sent to:
(1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701
[[Page 14291]]
Morrissette Drive, Springfield, Virginia 22152; and (2) Drug
Enforcement Administration, Attn: DEA Federal Register Representative/
DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests
for a hearing should also be sent to: Drug Enforcement Administration,
Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia
22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on February 2, 2022, Meridian Medical Technologies, LLC,
2555 Hermelin Drive, Saint Louis, Missouri 63144, applied to be
registered as an importer of the following basic class(es) of
controlled substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Morphine............................... 9300 II
------------------------------------------------------------------------
The company plans to import the control substance for analytical
and research purposes. No other activity for this drug code is
authorized for this registration.
Approval of permit applications will occur only when the
registrant's business activity is consistent with what is authorized
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import
of Food and Drug Administration-approved or non-approved finished
dosage forms for commercial sale.
Matthew J. Strait,
Deputy Assistant Administrator.
[FR Doc. 2022-05291 Filed 3-11-22; 8:45 am]
BILLING CODE 4410-09-P
